Literature DB >> 24743918

Protective effects of kaempferol on lipopolysaccharide-induced mastitis in mice.

Rongfeng Cao1, Kaiqiang Fu, Xiaopei Lv, Weishi Li, Naisheng Zhang.   

Abstract

Kaempferol isolated from the root of Zingiberaceae plants galangal and other Chinese herbal medicines have been reported to have anti-inflammatory properties. However, the anti-inflammatory effects of kaempferol on lipopolysaccharide (LPS)-induced mastitis are unknown and their underlying molecular mechanisms remain to be explored. The aim of this study was to evaluate the effects of kaempferol on LPS-induced mouse mastitis. The mouse model of mastitis was induced by injection of LPS through the duct of mammary gland. Kaempferol was injected 1 h before and 12 h after induction of LPS intraperitoneally. The present results showed that kaempferol markedly reduced infiltration of neutrophilic granulocyte, activation of myeloperoxidase (MPO), expression of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and interleukin-1β (IL-1β) in a dose-dependent manner, which were increased in LPS-induced mouse mastitis. Furthermore, kaempferol suppressed the phosphorylation of nuclear factor-κB (NF-κB) p65 subunit and the degradation of its inhibitor IκBα. All results suggest that anti-inflammatory effects of kaempferol against the LPS-induced mastitis possibly through inhibition of the NF-κB signaling pathway. Kaempferol may be a potential therapeutic agent for mastitis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24743918     DOI: 10.1007/s10753-014-9870-9

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  29 in total

Review 1.  A clinical perspective of IL-1β as the gatekeeper of inflammation.

Authors:  Charles A Dinarello
Journal:  Eur J Immunol       Date:  2011-05       Impact factor: 5.532

2.  NF-kappaB mediated IL-6 production by renal epithelial cells is regulated by c-jun NH2-terminal kinase.

Authors:  Simone de Haij; Astrid C Bakker; Reinier N van der Geest; Guy Haegeman; Wim Vanden Berghe; Jamil Aarbiou; Mohamed R Daha; Cees van Kooten
Journal:  J Am Soc Nephrol       Date:  2005-04-20       Impact factor: 10.121

Review 3.  NF-κB, inflammation, and metabolic disease.

Authors:  Rebecca G Baker; Matthew S Hayden; Sankar Ghosh
Journal:  Cell Metab       Date:  2011-01-05       Impact factor: 27.287

4.  Efficacy of extended pirlimycin hydrochloride therapy for treatment of environmental Streptococcus spp and Staphylococcus aureus intramammary infections in lactating dairy cows.

Authors:  Barbara E Gillespie; Hugh Moorehead; Phillip Lunn; Henry H Dowlen; David L Johnson; Ken C Lamar; Mark J Lewis; Susan J Ivey; John W Hallberg; S Ted Chester; Stephen P Oliver
Journal:  Vet Ther       Date:  2002

Review 5.  Economic effects of bovine mastitis and mastitis management: a review.

Authors:  T Halasa; K Huijps; O Østerås; H Hogeveen
Journal:  Vet Q       Date:  2007-03       Impact factor: 3.320

6.  Costs of clinical mastitis and mastitis prevention in dairy herds.

Authors:  G Y Miller; P C Bartlett; S E Lance; J Anderson; L E Heider
Journal:  J Am Vet Med Assoc       Date:  1993-04-15       Impact factor: 1.936

7.  Emodin ameliorates lipopolysaccharide-induced mastitis in mice by inhibiting activation of NF-κB and MAPKs signal pathways.

Authors:  Depeng Li; Naisheng Zhang; Yongguo Cao; Wen Zhang; Gaoli Su; Yong Sun; Zhicheng Liu; Fengyang Li; Dejie Liang; Bo Liu; Mengyao Guo; Yunhe Fu; Xichen Zhang; Zhengtao Yang
Journal:  Eur J Pharmacol       Date:  2013-03-13       Impact factor: 4.432

Review 8.  Myeloperoxidase: expressing inflammation and oxidative stress in cardiovascular disease.

Authors:  Nikolaos Anatoliotakis; Spyridon Deftereos; Georgios Bouras; Georgios Giannopoulos; Dimitrios Tsounis; Christos Angelidis; Andreas Kaoukis; Christodoulos Stefanadis
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

9.  Treatment with gentamicin on a murine model of protothecal mastitis.

Authors:  Ruilong Chang; Qiaoling Yang; Gang Liu; Yongxia Liu; Bowen Zheng; Jingliang Su; Bo Han
Journal:  Mycopathologia       Date:  2013-03-06       Impact factor: 2.574

Review 10.  Regulation and function of NF-kappaB transcription factors in the immune system.

Authors:  Sivakumar Vallabhapurapu; Michael Karin
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

View more
  7 in total

1.  Study the Mechanism of Gualou Niubang Decoction in Treating Plasma Cell Mastitis Based on Network Pharmacology and Molecular Docking.

Authors:  Zhaojing Wu; Qing Yang; Hongbo Ma
Journal:  Biomed Res Int       Date:  2022-06-15       Impact factor: 3.246

Review 2.  Zingiberaceae extracts for pain: a systematic review and meta-analysis.

Authors:  Shaheen E Lakhan; Christopher T Ford; Deborah Tepper
Journal:  Nutr J       Date:  2015-05-14       Impact factor: 3.271

3.  Novel Therapeutics Identification for Fibrosis in Renal Allograft Using Integrative Informatics Approach.

Authors:  Li Li; Ilana Greene; Benjamin Readhead; Madhav C Menon; Brian A Kidd; Andrew V Uzilov; Chengguo Wei; Nimrod Philippe; Bernd Schroppel; John Cijiang He; Rong Chen; Joel T Dudley; Barbara Murphy
Journal:  Sci Rep       Date:  2017-01-04       Impact factor: 4.379

4.  Herbal Supplement in a Buffer for Dry Eye Syndrome Treatment.

Authors:  Hung-Chang Chen; Zhi-Yu Chen; Tsung-Jen Wang; Victor J Drew; Ching-Li Tseng; Hsu-Wei Fang; Feng-Huei Lin
Journal:  Int J Mol Sci       Date:  2017-08-03       Impact factor: 5.923

5.  Formononetin Protects LPS-Induced Mastitis Through Suppressing Inflammation and Enhancing Blood-Milk Barrier Integrity via AhR-Induced Src Inactivation.

Authors:  Kaihe Xiang; Peng Shen; Ziyang Gao; Zhuoyu Liu; Xiaoyu Hu; Bin Liu; Yunhe Fu
Journal:  Front Immunol       Date:  2022-02-03       Impact factor: 7.561

6.  Active components and molecular mechanism of Syringa oblata Lindl. in the treatment of endometritis based on pharmacology network prediction.

Authors:  Xiao-Zhen Wang; Xue-Jiao Song; Chang Liu; Chen Xing; Tong Wu; Yue Zhang; Jing Su; Jing-You Hao; Xue-Ying Chen; Zhi-Yun Zhang; Yan-Hua Li; Yan-Yan Liu
Journal:  Front Vet Sci       Date:  2022-07-22

7.  Farrerol Relieve Lipopolysaccharide (LPS)-Induced Mastitis by Inhibiting AKT/NF-κB p65, ERK1/2 and P38 Signaling Pathway.

Authors:  Yanwei Li; Qian Gong; Wenjin Guo; Xingchi Kan; Dianwen Xu; He Ma; Shoupeng Fu; Juxiong Liu
Journal:  Int J Mol Sci       Date:  2018-06-14       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.